PLUTO, given your thorough knowledge of the industry, players, and marketplace, I have a question for you. As DECN continues to build out a very broad and innovative product line in the test strip space, how valuable is it for a well-financed current player to come in acquire the company (or assets) and use it is a ready-made product jumping off point to fuel their growth over the next 5-10 years (and retain Keith as the continued brains behind additional development)? Would a current player both see this as benefit and would they also be in a position to make sure a decision? Thanks
Bialy
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links